Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001

NCT06119659 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06119659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001
Lead sponsor
Zhejiang University
Phase
Phase 1
Overall status
Unknown status
Start date
November 20, 2023
Completion date
July 10, 2025
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b without inhibitor